JPIAMR project

Aim of the project/ Project proposal

Worldwide strategies to control antibiotic resistance and its consequences (mortality, costs) are being developed, but are currently insufficiently, as for example demonstrated in the unchanged European consumption rates of antibiotics during the last years (RAND, 2016). Preliminary studies have shown that Complementary and Alternative Medicine (CAM) practices and hospitals have lower antibiotic prescription rates and lower resistance rates compared to conventional practices based on additional prevention and treatment of infections strategies. In order to offer conventional physicians a safe and effective alternative to antibiotics and to reduce misprescribing and overprescribing of antibiotics broadly, the available practical expertise and scientific knowledge on CAM strategies must be explored and systemized. The working group will collect available information on the use of CAM strategies regarding the use and prescription of alternatives to antibiotics in The Netherlands, France, Germany, England and Switzerland. The Working Group will further focus on the development of an evidence and expertise based decision-making tool for (conventional) doctors and the implementation of this tool in the European countries.

  • Objectives of the JPIAMR project: The major objectives of the project are:
    • To provide an overview of expert and scientific knowledge on CAM/IM treatment of selected infectious diseases (Upper Respiratory Tract Infections (URTIs))
    • To develop a CAM/IM guidance document and if possible a first concept evidence- and expertise-based decision-making tool (DMT) for (conventional) doctors on a European level. A DMT commonly goes through several necessary steps:
      • Listing the options available
      • Quantifying the benefits and harms of each
      • Ensuring that the patient’s preferences are articulated and incorporated into the final decision
    • To provide a communication platform on the CAM/IM contribution
    • To develop a model for a sustainable process and organization for a phase II, in which more DMTs are developed.
  • National partners come from: Germany, Switzerland, The Netherlands, UK and probably France
  • Research: In order to get an overview of expert and scientific knowledge on CAM/IM treatment of Upper Respiratory Tract Infections (URTIs), we will do a survey among CAM experts in five countries and a systematic review of systematic review on CAM treatment of URTIs. The results of both studies will give input for a guidance document that is the basis for the development of a DMT. We combine Anthropsophic Medicine, Ayurveda, Homeopathy, TCM, Western Herbal.
  • Project deliverables:
    • Guidance documents (integrating the CAM expertise and the evidence
    • Decision-making tool (prototype)

Team members